Information pamphlet provided to participants on
physiological effect or nitrate-rich food [beetroot] and a comparable synthetic drug [erythropoietin] (PDF 828 KB) References 1. Baron DA, Martin DM, Abol Magd A: Doping in sports and its spread to at-risk populations: an international review. World Psychiatry 2007,6(2):118–123.PubMed 2. Lippi G, Franchini M, Guidi GC: Doping in competition or doping in sport? Br Med Bull 2008,86(1):95–107.CrossRefPubMed 3. Harmer PA: Anabolic-androgenic steroid use among young male and female athletes: is the game to blame? Br J Sp Med 2010, 44:26–31.CrossRef 4. Kayser B, Smith ACT: Globalisation of anti-doping: the reverse side of the medal. Br Med J 2008, 337:a584.CrossRef
5. Kayser B, Mauron A, Miah A: Current anti-doping policy: a critical appraisal. BMC Med Ethics 2007, 8:2.CrossRefPubMed 6. Kirkwood K: Considering www.selleckchem.com/products/AZD1152-HQPA.html harm reduction as the future of doping control CHIR98014 nmr policy in international sport. [http://journals.humankinetics.com/quest-back-issues/QUESTVolume61Issue2May/ConsideringHarmReductionastheFutureofDopingControlPolicyinInternationalSport] Quest 2009,61(2):180–190. 7. Smith AC, Stewart B: Drug policy in sport: hidden assumptions and inherent contradictions. [http://onlinelibrary.wiley.com/doi/10.1080/09595230701829355/abstract] Drug Alcohol Rev 2008,27(2):123–129.CrossRefPubMed 8. World Anti-Doping Programme [http://www.wada-ama.org/en/World-Anti-Doping-Program] 9. WADA Education & Awareness [http://www.wada-ama.org/en/Education-Awareness] 10. WADA Financial Statements [http://www.wada-ama.org/en/About-WADA/Funding] 11. Mazanov J, Huybers T, Connor J: Qualitative evidence of a primary intervention point for elite athlete doping. J Sci Med Sport 2010, in press. 12. Evans-Brown M, Kimergård A, McVeigh J: Elephant in the room? The methodological implications for public health research
Atezolizumab of performance-enhancing drugs derived from the illicit market. Drug Testing Analysis 2009,1(7):323–326.CrossRef 13. Gershwin ME, Borchers AT, Keen CL, Hendler S, Hagie F, Greenwood MRC: Public safety and dietary supplementation. Ann New York Acad Sci 2010, 1190:104–117.CrossRef 14. Cohen PA: American roulette – Contaminated dietary supplements. N Engl J Med 2009, 361:1523–1525.CrossRefPubMed 15. Corrigan B, Kazlauskas R: Medication use in athletes selected for doping control at the Sydney Olympics. Clin J Sport Med 2003, 13:33–40.CrossRefPubMed 16. Nisly NL, Gryxlak BM, Zimmerman MB, Wallace RB: Dietary supplement polypharmacy: an unrecognized public health problem? Evid Based Complement Alternat Med 2010, 7:107–113.CrossRef 17. Suzic Lazic J, Dikic N, Radivojevic N, Mazic S, Radovanovic D, Mitrovic N, Lazic M, Zivanic S, Suzic S: Dietary supplements and medications in elite sport – polypharmacy or real need? Scand J Med Sci Sports 2009, in press. 18.